These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9935015)

  • 1. Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty.
    Mickelson JK; Ali MN; Kleiman NS; Lakkis NM; Chow TW; Hughes BJ; Smith CW
    J Am Coll Cardiol; 1999 Jan; 33(1):97-106. PubMed ID: 9935015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?
    Mickelson JK; Lakkis NM; Villarreal-Levy G; Hughes BJ; Smith CW
    J Am Coll Cardiol; 1996 Aug; 28(2):345-53. PubMed ID: 8800108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.
    Simon DI; Xu H; Ortlepp S; Rogers C; Rao NK
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):528-35. PubMed ID: 9102172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris.
    Inoue T; Sohma R; Miyazaki T; Iwasaki Y; Yaguchi I; Morooka S
    Am J Cardiol; 2000 Nov; 86(10):1057-62. PubMed ID: 11074199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A; Wendel HP; Azevedo R; Ziemer G
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty.
    Neumann FJ; Ott I; Gawaz M; Puchner G; Schömig A
    J Am Coll Cardiol; 1996 Mar; 27(4):819-24. PubMed ID: 8613609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.
    Furman MI; Kereiakes DJ; Krueger LA; Mueller MN; Pieper K; Broderick TM; Schneider JF; Howard WL; Fox ML; Barnard MR; Frelinger AL; Michelson AD
    Am Heart J; 2001 Nov; 142(5):790-8. PubMed ID: 11685164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
    Hézard N; Metz D; Garnotel R; Droullé C; Potron G; Nguyen P
    J Mal Vasc; 2000 Dec; 25(5):343-348. PubMed ID: 11148396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIb/IIIa receptor antagonist (abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury.
    Kuo YR; Jeng SF; Wang FS; Huang HC; Wei FC; Yang KD
    J Surg Res; 2002 Sep; 107(1):50-5. PubMed ID: 12384064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity.
    Barnard MR; Linden MD; Frelinger AL; Li Y; Fox ML; Furman MI; Michelson AD
    J Thromb Haemost; 2005 Nov; 3(11):2563-70. PubMed ID: 16241954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty.
    Konstantopoulos K; Kamat SG; Schafer AI; Bañez EI; Jordan R; Kleiman NS; Hellums JD
    Circulation; 1995 Mar; 91(5):1427-31. PubMed ID: 7867183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction.
    Neumann FJ; Zohlnhöfer D; Fakhoury L; Ott I; Gawaz M; Schömig A
    J Am Coll Cardiol; 1999 Nov; 34(5):1420-6. PubMed ID: 10551687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty.
    Fredrickson BJ; Turner NA; Kleiman NS; Graziadei N; Maresh K; Mascelli MA; Effron MB; McIntire LV
    Circulation; 2000 Mar; 101(10):1122-9. PubMed ID: 10715258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty.
    Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Takabatake Y
    J Am Coll Cardiol; 1996 Nov; 28(5):1127-33. PubMed ID: 8890805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation.
    Inoue T; Uchida T; Sakuma M; Imoto Y; Ozeki Y; Ozaki Y; Hikichi Y; Node K
    J Am Coll Cardiol; 2004 Oct; 44(7):1408-14. PubMed ID: 15464320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin.
    Konstantopoulos K; Neelamegham S; Burns AR; Hentzen E; Kansas GS; Snapp KR; Berg EL; Hellums JD; Smith CW; McIntire LV; Simon SI
    Circulation; 1998 Sep; 98(9):873-82. PubMed ID: 9738642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty.
    Ahnadi CE; Boughrassa FF; Chapman-Montgomery ES; Poisson V; Gervais A; Okrongly D; Grant AM
    Thromb Haemost; 2004 Dec; 92(6):1207-13. PubMed ID: 15583725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of halothane and isoflurane on binding of ADP- and TRAP-6- activated platelets to leukocytes in Whole blood.
    de Rossi LW; Horn NA; Hecker KE; Robitzsch T; Hutschenreuter G; Rossaint R
    Anesthesiology; 2002 Jan; 96(1):117-24. PubMed ID: 11753011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.